Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2015 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (293)	5/30/2015 4:27:37 PM
From: Robohogs	Read Replies (1) \| Respond to of 407

What percentage of the 206 stocks is down this year? My percentage down is 20% and that is the difference between top ten performance and something above median but not top 10. Jon

To: BulbaMan who wrote (293)	6/5/2015 6:31:51 PM
From: BulbaMan	Read Replies (1) \| Respond to of 407

6/5/15 Contest update On Wednesday, Harvard announced they named a building after hedge fund billionaire John Paulson in exchange for $400 million. Earlier in the year, Chinese billionaire Gerald Chan paid Harvard $350 million to name a building after his dad. Here’s my idea. How about the winner of this year’s Contest picks Harvard as her/his charity on condition they name a building after yours truly. It would save me the tsuris of making a billion. And either Bulba Hall or Bulbaman Hall would be acceptable. Thanks in advance. Meanwhile, riding a team of immuno-oncology biotechs, Contest portfolios continued on their merry exuberant path. The Contest median closed Friday up 35.55% YTD (vs. up 30.70% YTD a week ago), the Nasdaq Biotech Index was up 20.93% YTD (vs. up 20.27% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index was up 30.74% YTD (vs. up 27.77% YTD a week ago). The Nasdaq Composite Index was up 7.02% YTD (vs. up 7.05% YTD a week ago). Helped by a booster shot from Advaxis, Contest leader, DEWDIL’s portfolio, up 96.52% YTD, edged nearer a double for the year. MCBIO’s portfolio, up 83.20% YTD and GUERL’s portfolio, up 78.90% YTD, held on to the number two and three positions. At Friday's close, 50 of the 51 Contest portfolios were now in the black with an impressive 38 beating the NBI and 32 beating the SPSIBI. The 206 Contest stock picks have an average YTD gain of 25.81% and a median YTD gain of 11.00%. Below is the Top Ten list. Also below are the week’s Top 5 & Bottom 5 Stocks. (Prices not converted to US$ in these Tables.) Portfolio adjustments: None (All corrections, especially adjustments for buyouts & splits, greatly appreciated.) Have a relaxing weekend biotechies! Peace & good health, Bulba 6/5/15 Rank Name Profit/Loss 1 DEWDIL 96,523 2 MCBIO 83,195 3 GUERL 78,904 4 DONS 77,647 5 IMAN 75,852 6 OLIVIER 69,547 7 CLARK 66,192 8 DANIEL 65,239 9 FRED 62,350 10 IJF 59,796 Week's Top 5 Gainers Symbol 5/29/15 6/5/15 Wk.%chg. IMGN 8.980 14.700 63.70% TBRA 13.140 17.840 35.77% ARDX 10.950 14.540 32.79% JUNO 52.640 68.360 29.86% INNL 11.740 14.800 26.06% Week's Worst 5 Losers Symbol 5/29/15 6/5/15 Wk.%chg. RGLS 14.120 10.590 -25.00% EKSO 1.760 1.398 -20.57% CALA 10.470 9.000 -14.04% FPRX 25.640 22.660 -11.62% AMF.TO 0.045 0.040 -11.11%